Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Lymphoma, Non-Hodgkin × Surveys and Questionnaires × 1 year × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 42 Neoplasms 25 Prostatic Neoplasms 22 Lung Neoplasms 11 Head and Neck Neoplasms 11 Pancreatic Neoplasms 8 Ovarian Neoplasms 7 Oropharyngeal Neoplasms 6 Hematologic Neoplasms 6 Gastrointestinal Neoplasms 6 Colorectal Neoplasms 6 Urinary Bladder Neoplasms 5 Neoplasm Metastasis 5 Multiple Myeloma 5 Esophageal Neoplasms 5 Depression 5 Brain Neoplasms 5 Sarcoma 4 Motor Activity 4 Lymphoma 4 Endometrial Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Rectal Neoplasms 3 Pain 3 Osteosarcoma 3 Melanoma 3 Genetic Predisposition to Disease 3 Fatigue 3 Communication 3 Chronic Pain 3

Interventions

Cyclophosphamide 58 Rituximab 47 fludarabine 38 fludarabine phosphate 25 obinutuzumab 17 venetoclax 16 Lenalidomide 16 ibrutinib 15 Etoposide 14 Prednisone 13 pirtobrutinib 12 Whole-Body Irradiation 12 Mycophenolic Acid 11 Melphalan 11 Bendamustine Hydrochloride 11 Tacrolimus 10 Specimen Handling 10 Filgrastim 10 Doxorubicin 10 Biopsy 10 Vincristine 9 Magnetic Resonance Spectroscopy 9 Granulocyte Colony-Stimulating Factor 9 pembrolizumab 8 Stem Cell Transplantation 8 Peripheral Blood Stem Cell Transplantation 8 Nivolumab 8 Gemcitabine 8 Cytarabine 8 tocilizumab 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05583318 2025-07-23

LymphoVie 2

Centre Hospitalier Universitaire Dijon

Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon ⚡